Drug intelligence / Profile preview

antisnake venom serum

Development stage
Unknown
Lead developer
Lexicare Pharma
Modality
Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Antisnake venom serum is a biological therapeutic agent used to treat envenomation caused by snake bites. It is composed of polyclonal antibodies, typically IgG or F(ab')2 fragments, purified from the plasma of animals (usually horses or sheep) that have been immunized with specific snake venoms. The serum works by binding to and neutralizing the toxic proteins and enzymes in the venom, such as neurotoxins, phospholipases, and metalloproteinases, thereby preventing or reversing systemic toxicity. Lexicare Pharma is a developer and manufacturer of this serum, which is often produced in a polyvalent form to provide broad coverage against the most clinically significant venomous snakes in a particular region, such as the Indian Cobra, Common Krait, Russell's Viper, and Saw-scaled Viper.

Brand names
ASVSAnti-Snake Venom Serum
Other names
snake antivenomantiveninsnake antivenom immunoglobulinsASVpolyvalent antisnake venom serum

Beyond the preview

Go deeper on antisnake venom serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antisnake venom serum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call